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1016-142 Falls and Bradyarrhythmic Disorders 
~@ta M. Seifu, Joanna Cox, Rod Bexton. Rose Anne Kenny, Royal Victoria Infirmary 
Newcastle upon Tyne, United Kingdom. 
Background: Falls are a major health care and cost priority. Eight percent of persons 
aged r 70 years attend the Emergency Depaltment each year because of a fall. One- 
third of failers are hospitalised. The cost of falls to the US health care system in 1999 was 
32.4 billion dollars. In patients with orthostatic hypotension (OH) end cardioinhibitory 
carotid sinus syndrome (CICSS), ZO-30% of cardiovascular episodes present as falls and 
not syncope either because of amnesia for loss of consciousness (LOC) or balance 
instability during hypotension. In patients with CICSS who fall cardiac pacing reduces 
subsequent falls by over 70%.(‘) Other bradyarrhythmic disorders - atrioventricular block 
(AVB) and sick sinus syndrome (SSS) are particularly prevalent in older adults, but the 
incidence of falls in this group is not known. The purpose of this study is to compare the 
incidence of falls in older adults with AVB and SSS with case controls. 
Methods: Consecutive subjects who had pacemakers implanted were screened. Those 
with AVB and SSS and who were not cognitively impaired (able to provide accurate his- 
toty) underwent further detailed assessment. Consecutive age and gender-matched 
admissions to coronary care unit who did not have underlying conduction disease were 
similarly studied. 
Results: Eighty-one subjects were included, 31 paced for bradyartiythmic disorders (17 
male; mean age 77.1 * 7.6 years)(AVB 16. SSS 13) and 50 controls (26 male; mean age 
77f 6.5 years). There were 134 (range O-100) falls in the bradyarrhythmic group and 12 
(range O-2) in the control group. Twelve (39%) of the paced patients reported at least one 
fall in the previous 12 months compared to 16% of the controls; p=. 06t’). There was no 
significant difference between the 2 groups with respect to any recognised risk factors for 
falls. 
Conclusion: Prospective studies of symptom-rhythm correlation in bradyarrhythmic dis- 
orders are difficult. This is the first series that clearly shows a significant association 
between bradyarrhythmic disorders and falls. 
1. Carotid sinus syndrome: A modifiable risk factor for non-accidental falls in older adults. 
Kenny RA, Richardson DA, Steen N, et al; JACC (in press November 2001) 
2 Fisher’s exact test 
1016-143 24-Hour Ambulatory Electrocardiography Is Unhelpful 
in the Investigation of Older Persons With Recurrent 
Falls 
John DavisQo, Rose Anne Kenny, Cardiovascular Investigation Unit, Newcastle upon 
Tyne. United Kingdom. 
Background: 24-hour ambulatory ECG is often used to assess failers. There is little evi- 
dence that the investigation aids diagnosis. We prospectively compared 24.hour ECG in 
older recurrent failers and controls. 
Methods: 129 consecutive patients, age ~65. attending the ER. with t2 falls in last year. 
103 age and sex-matched case controls with no falls in last 3 years. 24.hour ECG 
recordings analysed for prevalence of abnormalities (Bass criteria) and correlation 
between symptoms and abnormalities. 
Results: Mean age failers 76.7 years (SDi6.3) vs 75.0 (SDi5.7) p=O.O4. Male 42(33%) 
vs 41(40%), p=O.272. No significant differences in prevalence of IHD, 35 (27%) in failers 
YS 19 (16%), p=O.l59, atrial fibrillation 9 (7%) vs 4 (4%), pzO.395, beta blocker use 30 
(23%) vs 14 (14%), p=O.O66, calcium antagonists 24 (19%) vs 12 (12%), p=O.201, AV 
blocking agents 5 (4%) vs 2 (2%), p=O.467. Failers more likely to have hypertension 47 
(36%) vs 23 (22%). p=O.O22, and diabetes 16 (14%) vs 5 (5%), p=O.O26. Abnormalities 
found m 67 (52%) of recordings in failers and 41 (40%) of controls, p=O.O65. No signifi- 
cant differences in the prevalence of different abnormalities found - see Table. Mild 
symptoms occurred in 11 (6%) of failers YS 13 (13%) of controls, p=O.309. No symptoms 
correlated with arrhythmia. No patient fell during monitoring. 
Conclusion: Multiple abnormalities are present on 24-hour ECG recordings in all sub- 
jects aged 265 years. 24-hour ECG does not help in the investigation of recurrent falls. 
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1016-144 Incidence and Predictors of Atrial Flutter/Fibrillation in 
the General Population 
j-lumberto Vim, Juan Granada, William Urtbe, Po-Huang Chyou, Karen Maasaen, 
Param Sharma, Peter N. Smith, John Hayes, Marshfietd Clinic, Marshfield, Wisconsin, 
Marshfield Medical Research and Education Foundation, Marshfield, Wisconsin. 
BACKGROUND: Previous epidemiologic and clinical research have advanced oaf 
understanding of atrial flutter (AFL) and atrial fibrillation (AFIB). Unlike AFL and AFIB 
however, nothing but isolated case reports of atrial flutter/fibrillation (AFL/FIB) have 
appeared in the literature. We determined the incidence and predictors of AFUFIB in the 
general population. METHODS: The Marshfield Epidemiologic Study Area (MESA): a 
database that captures nearly all medical care among its -60,000 residents was used to 
ascertain all new cases of AFUFIB diagnosed from 7/l/91 to 6/30/95. To identify predis- 
posing risk factors, we employed an age- and gender-matched case-control study design 
using 6 additional variables. Patients with AFL and/or AFIB but without AFUFIB were 
excluded by designing an strict ECG diagnostic criteria for AFL/FIB that required promi- 
nent flutterifibrillatory waves (“f/f”) > 1 .O mm an amplitude with variable “f’ wave morphol- 
ogy AND highly irregular “f-f” intervals with atrial rates of >340 beats per minute. Quality 
assurance methods to ensure data integrity were Implemented and exceeded 96%. 
RESULTS: A total of 169 new cases of AFUFIB were diagnosed for an overall incidence 
rate of 62 per 100,OQO person-years. Age group analysis revealed incidence rates rang 
ing from 6.25/100,000 in subjects less than 50 years old to 536/100,000 in persons 60 
and beyond. Adjusted for age, the incidence rate of AFUFIB in men (107/100.000 per- 
son-years, 95% Cl, 1.02 to 1.49) was 1.7 times that of women (66/100,000 person-years, 
95% Cl, 0.44 to 0.73). Compared to controls, patients with AFUFIB were twice as likely 
to have had previous cerebrovascular events (RR 2.27.95% Cl, 1.12 to 4.62) or conges- 
tive heart failure (RR 1.92, 95% Cl, 0.96 to 3.76). CONCLUSIONS: 1) This study, the first 
epidemiologic investigation of AFUFIB, suggests AFUFIB is much more common than 
previously appreciated. 2) If our findings were applicable to the entire U.S. population, we 
estimate 175,000 new cases of AFL/FIB diagnosed in this country annually. 3) At highest 
risk of developing AFUFIB are men, the elderly and individuals with previous cerebrovas- 
cular disease or congestive heart failure. 
1016-145 Whet Is the Optimal Anticoagulation Intensity to 
Prevent Stroke in Patients With Atria1 Fibrlllatlon a=75 
Versus ~75 Years Old? The AnTicoagulation and Risk 
Factors In Atrial Fibrillation (ATRIA) Study 
,&&,.J&, Elaine M. Hylek. Yuchiao Chang, Lori E. Henault, Kathleen A. Phillips, Daniel 
E. Singer, Kaiser fermsnente of Northern Califomie, Oakland, California, Massachusetts 
General Hospital, Boston. Massachusetts. 
BACKGROUND: Warfarin effectively reduces risk of ischemic stroke in patients with 
nonvalvular atrial fibrillation (NVAF). A target INR of 2.0-3.0 is currently recommended, 
but whether elderly patients (x75 years) would achieve the same benefit at a lower INR 
is controversial. 
METHODS: We conducted a nested case-control study of the risk of stroke by INR within 
the ATRIA cohort of 13,559 NVAF patients. In this cohort, we identified anticoagulated 
case patients with validated ischemic stroke and matched anticoagulated control sub- 
jects. We used conditional logistic regression to assess the independent association 
between INR and stroke stratified by age (x75 vs. ~75 years) after adjusting for other 
stroke risk factors in NVAF (prior stroke, hypertension, diabetes, heart failure, and coro- 
nary disease). 
RESULTS: Among 13,559 NVAF patients, 172 anticoagulated cases of ischemic stroke 
and 660 matched anticoagulated controls without stroke were identified. The majority of 
strokes occurred at INRs ~2.0. The INRs at the time of admission in stroke patients fol- 
Failers Controls Fishers Exact 
(n=129) ln=103) Test 
Pauses22seconds 
Ventricular Tachycardia 23 beats 
Mobitz II heart block 
Bradycardia < 30bpm 
Bradycardia 30-39bpm 
Paroxysmal Supraventricular Tachycardia 
210 beats at a rate 2150bpm 
Ventricular ectopy 230 beats / hr 
Paroxvsmal Atrial Fibrillation 
6 (6%) 6 (6%) 
5 (4%) 3 (3%) 
1 (1%) 0 (0%) 
0 (0%) l(l%) 
10 (6%) 5 (5%) 
14 (11%) 13 (13%) 
45 (35%) 
6 (5%) 
24 (23%) 
4 (4%) 
0.795 
1 .ooo 
1.000 
0.444 
0.431 
0.666 
0.061 
1.000 
l5zL9 2JlGI 2sLQ23A 
~75 years (n=79) 30% 36% 14% 13% 5% 
~75 years (n=93) 37% 24% 14% 12% 13% 
Compared to INR 2.0-3.0, INR 1.5-l .9 was associated with an adjusted 3.6.fold (95% Cl: 
1.9-6.9) increased odds of stroke in patients ~75 years, and an adjusted 2.0-fold (1 .l- 
4.0) increased odds of stroke in patients x75 years. In both age groups, an INR cl.5 
was associated with a 6-to-7.fold increased odds of stroke. 
CONCLUSION: An INR ~2.0 does not provide effective protection against ischemic 
stroke among elderly or younger patients with NVAF. 
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1037-l 53 Antiarrhythmic Effect of Nonexcitatory Signal Delivery 
in Patients With Severe Lefi Ventricular Dysfunction 
Nassir F. Marro&& Andrea Natale. Cleveland Clinic Foundation, Cleveland, Ohio, For 
the Halter core laborato~ on behalf of the investigators. 
Objective: Preliminary data in animal models and patients have suggested that non- 
excitatory signal (NES) delivery improve lefl ventricular function. In this study we report 
the effect on electrocardiographic parameters and arrhythmias by chronic NES delivery 
in patients with sever left ventricular (LV) dysfunction. 
